These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1261 related articles for article (PubMed ID: 27557526)
1. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review. Ashby LS; Smith KA; Stea B World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526 [TBL] [Abstract][Full Text] [Related]
2. Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: efficacy and toxicity. Miglierini P; Bouchekoua M; Rousseau B; Hieu PD; Malhaire JP; Pradier O Clin Neurol Neurosurg; 2012 Nov; 114(9):1222-5. PubMed ID: 22464950 [TBL] [Abstract][Full Text] [Related]
3. The effects of the NICE Technology Appraisal 121 (gliadel and temozolomide) on survival in high-grade glioma. Barr JG; Grundy PL Br J Neurosurg; 2012 Dec; 26(6):818-22. PubMed ID: 22715955 [TBL] [Abstract][Full Text] [Related]
4. First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience. Bock HC; Puchner MJ; Lohmann F; Schütze M; Koll S; Ketter R; Buchalla R; Rainov N; Kantelhardt SR; Rohde V; Giese A Neurosurg Rev; 2010 Oct; 33(4):441-9. PubMed ID: 20706757 [TBL] [Abstract][Full Text] [Related]
5. Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas. Noël G; Schott R; Froelich S; Gaub MP; Boyer P; Fischer-Lokou D; Dufour P; Kehrli P; Maitrot D Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):749-55. PubMed ID: 21300471 [TBL] [Abstract][Full Text] [Related]
6. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. McGirt MJ; Than KD; Weingart JD; Chaichana KL; Attenello FJ; Olivi A; Laterra J; Kleinberg LR; Grossman SA; Brem H; Quiñones-Hinojosa A J Neurosurg; 2009 Mar; 110(3):583-8. PubMed ID: 19046047 [TBL] [Abstract][Full Text] [Related]
7. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840 [TBL] [Abstract][Full Text] [Related]
8. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer. Shapira-Furman T; Serra R; Gorelick N; Doglioli M; Tagliaferri V; Cecia A; Peters M; Kumar A; Rottenberg Y; Langer R; Brem H; Tyler B; Domb AJ J Control Release; 2019 Feb; 295():93-101. PubMed ID: 30605703 [TBL] [Abstract][Full Text] [Related]
9. Biodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: the French experience. Menei P; Metellus P; Parot-Schinkel E; Loiseau H; Capelle L; Jacquet G; Guyotat J; Ann Surg Oncol; 2010 Jul; 17(7):1740-6. PubMed ID: 20443147 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma. De Bonis P; Anile C; Pompucci A; Fiorentino A; Balducci M; Chiesa S; Maira G; Mangiola A Acta Neurochir (Wien); 2012 Aug; 154(8):1371-8. PubMed ID: 22718138 [TBL] [Abstract][Full Text] [Related]
11. The role of Gliadel wafers in the treatment of high-grade gliomas. Bregy A; Shah AH; Diaz MV; Pierce HE; Ames PL; Diaz D; Komotar RJ Expert Rev Anticancer Ther; 2013 Dec; 13(12):1453-61. PubMed ID: 24236823 [TBL] [Abstract][Full Text] [Related]
12. The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis. Xing WK; Shao C; Qi ZY; Yang C; Wang Z Drug Des Devel Ther; 2015; 9():3341-8. PubMed ID: 26170620 [TBL] [Abstract][Full Text] [Related]
13. A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients. Pan E; Mitchell SB; Tsai JS J Neurooncol; 2008 Jul; 88(3):353-7. PubMed ID: 18389176 [TBL] [Abstract][Full Text] [Related]
14. Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblastoma multiforme. Smith KA; Ashby LS; Gonzalez LF; Brachman DG; Thomas T; Coons SW; Battaglia M; Scheck A J Neurosurg; 2008 Dec; 109 Suppl():106-17. PubMed ID: 19123896 [TBL] [Abstract][Full Text] [Related]
15. Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis. Chowdhary SA; Ryken T; Newton HB J Neurooncol; 2015 Apr; 122(2):367-82. PubMed ID: 25630625 [TBL] [Abstract][Full Text] [Related]
16. O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide. Lechapt-Zalcman E; Levallet G; Dugué AE; Vital A; Diebold MD; Menei P; Colin P; Peruzzy P; Emery E; Bernaudin M; Chapon F; Guillamo JS Cancer; 2012 Sep; 118(18):4545-54. PubMed ID: 22359215 [TBL] [Abstract][Full Text] [Related]
17. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651 [TBL] [Abstract][Full Text] [Related]
18. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas]. Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324 [TBL] [Abstract][Full Text] [Related]
19. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme. Reddy K; Damek D; Gaspar LE; Ney D; Waziri A; Lillehei K; Stuhr K; Kavanagh BD; Chen C Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):655-60. PubMed ID: 22483738 [TBL] [Abstract][Full Text] [Related]
20. Loco-regional treatments in first-diagnosis glioblastoma: literature review on association between Stupp protocol and Gliadel. Salmaggi A; Duri S; Silvani A; Gaviani P; Milanesi I; Casali C; Di Meco F Neurol Sci; 2011 Nov; 32 Suppl 2():S241-5. PubMed ID: 21983866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]